During the session of Thursday, December 29, 2022 the following shares, currencies or indices reached their highest level of valuation over a period of 1 year
| Last name | Record price | Change over 1 year |
|---|---|---|
| Manutan International | 103.50 | 44.96% |
| Mersen | 38.75 | 4.17% |
| Close.Case.Mun.Cane | 1350.00 | 6.30% |
| Ipsos | 58.80 | 43.59% |
| Consort NT | 65.00 | 0.00% |
| Selectiente | 101.00 | 4.66% |
| Part.Indles Mini. | 37.00 | 230.36% |
| Altur Investment | 7.90 | 36.21% |
| Ekinops | 8.43 | 9.48% |
| Ashler and Manson | 4.58 | 106.31% |
| Veralia | 32.18 | 3.47% |
| Entech | 9.64 | 37.71% |
| Flo Group | 21.00 | 35.48% |
During the day of Thursday, December 29, 2022 the following stocks reached their lowest level of valuation over a period of 1 year
| Last name | Record price | Change over 1 year |
|---|---|---|
| coil | 6.70 | -19.08% |
| BIOSENIC | 0.096 | -85.23% |
| DMS Imaging | 0.051 | -77.16% |
| aurea | 6.32 | -22.55% |
| Consort NT | 65.00 | 0.00% |
| Orpea | 5.70 | -93.51% |
| Hybrigenics | 0.056 | -56.55% |
| Metabolic Explorer | 1,204 | -82.40% |
| Tarkett | 11.38 | -38.82% |
| Onxeo | 0.126 | -70.31% |
| Predilife | 5.10 | -24.44% |
| Sgamnasdaq100Lev | 382.10 | -60.25% |
| Weya | 1.18 | -66.09% |
| Colipays | 4.06 | -54.64% |
| Global Bioenergies | 2.95 | -41.70% |
| Erytech Pharma | 0.285 | -86.46% |
| Genomic Vision | 0.031 | -85.80% |
| LYXOR ETF PEA NASDAQ100 | 40.125 | -30.69% |
| Lucibel | 0.628 | -17.15% |
| poxels | 0.882 | -81.67% |
| Biophytis | 0.041 | -91.94% |
| Navya | 0.036 | -98.19% |
| DBT | 0.01 | -70.32% |
| CGG BSA2 | 0.001 | -91.94% |
| Affluent Medical | 1.65 | -70.54% |
| Safe | 0.001 | -99.76% |
| Veom Group | 1.43 | -66.15% |
| Solocal Group | 0.604 | -49.02% |
| HDF (Hydrogen from France) | 20.85 | -22.63% |
| Europlasma | 0.744 | -99.94% |
| Vergnet | 6.96 | -99.14% |
| Lyxor MSCI WITTR | 415.00 | -29.09% |
| MULTI NASDAQ 100 | 40,272 | -30.50% |
| Cnova NV | 2.70 | -61.54% |
Find all the records reached by stock market values, with a consultation of the complete history.
(c) abcbourse.com
Did you like this article ? Share it with your friends with the buttons below.
